STN: 125428
Proper Name: Hepatitis B Vaccine (Recombinant), Adjuvanted
Tradename: HEPLISAV-B
Manufacturer: Dynavax Technologies Corporation
Indications:
- HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus.
- HEPLISAV-B is approved for use in adults 18 years of age and older.
Product Information
Supporting Documents
-
Content current as of:
09/12/2024
